Rite Aid Anti-Itch

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Rite Aid Anti-Itch
Generic name: DIPHENHYDRAMINE HCL 2%
Manufacturer: Rite Aid
Product type: HUMAN OTC DRUG
SPL set ID: e33898d8-1b8b-5c0b-e053-2995a90add08
SPL ID: 2956dcd8-2fd3-cea7-e063-6294a90aee82
Version: 2
Effective date: 2024-12-15
Source export date: 2026-09-28
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:15:49

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Rite Aid Anti-Itch	openfda.brand_name
generic name		DIPHENHYDRAMINE HCL 2%	openfda.generic_name
manufacturer name		Rite Aid	openfda.manufacturer_name
ndc	package	11822-1070-3	openfda.package_ndc
ndc	product	11822-1070	openfda.product_ndc
ndc11	package	11822107003	derived:openfda.package_ndc
rxcui		1049880	openfda.rxcui
spl id		2956dcd8-2fd3-cea7-e063-6294a90aee82	id
spl set id		e33898d8-1b8b-5c0b-e053-2995a90add08	set_id
unii		TC2D6JAD40	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only. Do not use on large areas of the body, with any other products containing diphenhydramine, even one taken by mouth. Ask a doctor before use on chicken pox or measles. When using this product avoid contact with eyes. Stop use and ask a doctor if condition worsens, if symptoms persist for more than 7 days or clear up and occur again within a few days.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.